Shares of Subsea 7 S.A. (OTCMKTS:SUBCY – Get Rating) have been assigned a consensus recommendation of “Moderate Buy” from the six ratings firms that are covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is $101.75.
A number of equities research analysts have weighed in on the company. Societe Generale lowered their price target on Subsea 7 from 113.00 to 112.00 and set a “buy” rating on the stock in a research report on Wednesday, June 15th. Barclays raised their price target on Subsea 7 from 110.00 to 125.00 and gave the company an “overweight” rating in a research report on Thursday, April 14th.
Subsea 7 Price Performance
OTCMKTS:SUBCY opened at $8.93 on Thursday. The stock has a fifty day moving average of $8.61 and a 200 day moving average of $8.51. Subsea 7 has a 52-week low of $6.47 and a 52-week high of $10.90. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.24 and a current ratio of 1.26. The firm has a market capitalization of $2.66 billion, a price-to-earnings ratio of 178.60 and a beta of 1.88.
Subsea 7 Company Profile
Subsea 7 SA delivers offshore projects and services for the evolving energy industry worldwide. It provides subsea field development products and services, including project management, design and engineering, procurement, fabrication, survey, installation, and commissioning of production facilities on the seabed and the tie-back of its facilities to fixed or floating platforms or to the shore.
- Get a free copy of the StockNews.com research report on Subsea 7 (SUBCY)
- MarketBeat: Week in Review 7/25 – 7/29
- Procter’s Earnings Start To Show Weakness In Q4
- The One Question You Have to Ask Before Investing in INTC Stock
- Home Depot: A Beautiful Boring Stock to Navigate a Bear Market
- Could CRISPR Therapeutics be a Moonshot Hiding in Plain Sight?
Receive News & Ratings for Subsea 7 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Subsea 7 and related companies with MarketBeat.com's FREE daily email newsletter.